DENVER, CO, June 2 /CNW Telbec/ - Medical International Technology Inc.
(MDLH.PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is sad to
announce the passing of Mr. Michel Bayouk, our former Corporate Secretary,
Principal Accounting Officer and Director.
On May 16th 2009, Mr. Michel Bayouk tendered his resignation from Medical
International Technology Inc. as a Board member, secretary and principal
accounting officer due to health related reasons.
June 1st 2009, Mr. Bayouk passed away at a Montreal hospital.
Mr. Bayouk had worked with Mr. Karim Menassa for over the past 25 years
and had been working with Medical International Technology since its inception
Mr. Bayouk will be remembered for his professionalism, honesty and most
of all his heart of gold.
On behalf of all Medical International Technology's employees,
shareholders, and myself, we send our deepest sympathies to his family.
Karim Menassa, President
On Behalf of the Board of Directors
About Medical International Technology, Inc. MIT CANADA, with offices in
Montreal, is a subsidiary of Denver, Colorado-based Medical International
Technology, Inc. (MIT USA), which specializes in the development, production,
marketing and sale of needle-free injectors both for humans and animals, for
individual and mass vaccinations.
The statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties, including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development and acquisition of new product lines and services, government
approval processes, the impact of competitive products or pricing a
technological changes, the effect of economic conditions and other
uncertainties, and the risk factors set forth from time to time in the
Company's SEC reports, including but not limited to its annual report on Form
10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.
Medical International Technology Inc. takes no obligation to update or correct
For further information:
For further information: Karim Menassa, President, On Behalf of the
Board of Directors, (514) 339-9355; email@example.com